R&D Contract Service

Complete this 4-step form to receive a PDF Quote on your project Cost & Time.

1
Step 1 _{Target Type}
2
Step 2 _{Target Details}
3
Step 3 _{Time & Deliverables}
4
Step 4 _{Contact Info}

Intellectual Property (IP):
Aptagen owns its proprietary processes of aptamer development; however, the Client will own 100% of the rights to the aptamers Aptagen develops for the Client. Client contracts Aptagen to perform the R&D, the Client owns the IP.

PRICE MATCH GUARANTEE: Contact Us. We will make every effort to match any competitor’s quote (for equivalent services). Just provide documentation. Thank you.

FAQs aml-gtc111422 aml-gtc042324

Depending on Client needs, the project may be tailored to meet certain milestone objectives such as:

High Affinity (Kd) AND High Specificity; eliminate (false-positive) cross-reactivity.
Wide dynamic range between positive and negative samples (LOD)
Activation (EC50) or inhibition (IC50) against a target enzyme
Identification of unknown and unique biomarkers in serum, blood, or tissue samples
Cell or tissue-targeting for drug delivery
Convert an already existing aptamer into an apta-beacon™ to detect analytes free in solution (see Apta-Beacons™)

Small Organic

Custom develop aptamers against targets or antigens < 2,000 Daltons.

Peptide

Custom develop aptamers against peptides.

Protein

Custom develop aptamers against small to large proteins.

Cells (Eukaryotic)

Custom develop aptamers against transfected cell lines for surface binding or internal targeting.

Tissue

Custom develop aptamers against various tissues.

Whole-Animal

Custom develop aptamers targeting organs and tissues in vivo for drug delivery or imaging applications.

Other

Custom develop aptamers against your unique target. Quote Will Be Submitted.

Bacteria (Prokaryotic)

Custom develop aptamers against bacteria.

The target sample(s) do not have to be pure; crude target sample(s) are acceptable.

Phase I: Library Enrichment – SELEX (1-2 months)

Phase II: Polyclonal Sequencing & Bioinformatic Analysis (2-3 weeks)

Phase III: High-throughput Screen of Monoclonal Candidates (2-3 weeks)

Phase IV: Candidate Synthesis & Qualitative Assessment (1-4 weeks)

Phase V: Quantitative Assessment of Affinity & Specificity (1 month)

Phase VI (Optional): Optimization & Assay Development (1-2 months)

Project Quote Inquiry

Target Name*

Exact identity of target not needed until NDA is signed.
Target Type*
Desired Aptamer Type*
Application Type*
Reagent
Comments
How did you hear?*
If you selected "other", please explain here
Name*
First Last
Organization*
Title*
Phone*
Extension
Address*
Street Address Address Line 2 City State / Province ZIP / Postal Code Country
Region*
Conferences Attended
Email*
CAPTCHA

Thank you for contacting Aptagen regarding your aptamer development needs. We can develop aptamers against your target(s) of interest.

Previous Next Submit for Quote

Complete this 4-step form to receive a PDF Quote on your project Cost & Time.

R&D Contract Service

Step 1 Target Type

Step 2 Target Details

Step 3 Time & Deliverables

Step 4 Contact Info

>>Phase I: Library Enrichment – SELEX (1-2 months)

>>Phase II: Polyclonal Sequencing & Bioinformatic Analysis (2-3 weeks)

>>Phase III: High-throughput Screen of Monoclonal Candidates (2-3 weeks)

>>Phase IV: Candidate Synthesis & Qualitative Assessment (1-4 weeks)

>>Phase V: Quantitative Assessment of Affinity & Specificity (1 month)

>>Phase VI (Optional): Optimization & Assay Development (1-2 months)

Project Quote Inquiry

Step 1 _{Target Type}

Step 2 _{Target Details}

Step 3 _{Time & Deliverables}

Step 4 _{Contact Info}